P

Inventor

SASU BARBRA JOHNSON

US25 patents
⚠️ This page may combine multiple inventors who share the name “SASU BARBRA JOHNSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALLOGENE THERAPEUTICS INC

13 patents
US11673953B2Jun 13, 2023

DLL3 targeting chimeric antigen receptors and binding agents

ALLOGENE THERAPEUTICS INC9 citations81
US11072644B2Jul 27, 2021

Inhibitory chimeric antigen receptors

ALLOGENE THERAPEUTICS INC2 citations68
US12215347B2Feb 4, 2025

Chimeric antigen receptors with enhanced signaling and activities and uses thereof

ALLOGENE THERAPEUTICS INC0 citations61
US11781248B2Oct 10, 2023

Anti-TALEN antibodies and uses thereof

ALLOGENE THERAPEUTICS INC0 citations60
US12043655B2Jul 23, 2024

Constitutively active chimeric cytokine receptors

ALLOGENE THERAPEUTICS INC0 citations59
US11786553B2Oct 17, 2023

Chimeric cytokine receptors bearing a PD-1 ectodomain

ALLOGENE THERAPEUTICS INC0 citations59
US12447178B2Oct 21, 2025

Method of treatment using anti-CD19 rituximab-resistant chimeric antigen receptors

ALLOGENE THERAPEUTICS INC0 citations57
US12404315B2Sep 2, 2025

Protease-activating CD45-gate CAR

ALLOGENE THERAPEUTICS INC0 citations57
US11896617B2Feb 13, 2024

Polynucleotides encoding rituximab-resistant chimeric antigen receptors

ALLOGENE THERAPEUTICS INC0 citations57
US12528856B2Jan 20, 2026

Chimeric cytokine receptors comprising TGF β binding domains

ALLOGENE THERAPEUTICS INC0 citations56
US12036243B2Jul 16, 2024

BCMA CAR-T cells with enhanced activities

ALLOGENE THERAPEUTICS INC1 citations56
US12163153B2Dec 10, 2024

Methods of manufacturing allogeneic CAR T cells

ALLOGENE THERAPEUTICS INC0 citations54
US11732041B2Aug 22, 2023

Antibodies against 4G7-derived chimeric antigen receptors

ALLOGENE THERAPEUTICS INC0 citations50

PFIZER

11 patents

CELLECTIS

1 patent